Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of Directors
- Monday, September 26, 2022, 7:11
- PR Newswire
- Add a comment
NORWOOD, Mass., Sept. 26, 2022 /PRNewswire/ — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), an immunology company, today announced the appointment of Anne Altmeyer, PhD, MBA, MPH to its board of directors. “Anne is a dynamic leader with a proven track…
About the Author
admin has written 20652 stories on this site.